Back to Search Start Over

An improved radiosynthesis of O-(2-[ 18 F]fluoroethyl)-O-(p-nitrophenyl)methylphosphonate: A first-in-class cholinesterase PET tracer.

Authors :
Neumann KD
Thompson CM
Blecha JE
Gerdes JM
VanBrocklin HF
Source :
Journal of labelled compounds & radiopharmaceuticals [J Labelled Comp Radiopharm] 2017 Jun 15; Vol. 60 (7), pp. 337-342. Date of Electronic Publication: 2017 May 15.
Publication Year :
2017

Abstract

O-(2-Fluoroethyl)-O-(p-nitrophenyl) methylphosphonate 1 is an organophosphate cholinesterase inhibitor that creates a phosphonyl-serine covalent adduct at the enzyme active site blocking cholinesterase activity in vivo. The corresponding radiolabeled O-(2-[ <superscript>18</superscript> F]fluoroethyl)-O-(p-nitrophenyl) methylphosphonate, [ <superscript>18</superscript> F]1, has been previously prepared and found to be an excellent positron emission tomography imaging tracer for assessment of cholinesterases in live brain, peripheral tissues, and blood. However, the previously reported [ <superscript>18</superscript> F]1 tracer synthesis was slow even with microwave acceleration, required high-performance liquid chromatography separation of the tracer from impurities, and gave less optimal radiochemical yields. In this paper, we report a new synthetic approach to circumvent these shortcomings that is reliant on the facile reactivity of bis-(O,O-p-nitrophenyl) methylphosphonate, 2, with 2-fluoroethanol in the presence of DBU. The cold synthesis was successfully translated to provide a more robust radiosynthesis. Using this new strategy, the desired tracer, [ <superscript>18</superscript> F]1, was obtained in a non-decay-corrected radiochemical yield of 8 ± 2% (n = 7) in >99% radiochemical and >95% chemical purity with a specific activity of 3174 ± 345 Ci/mmol (EOS). This new facile radiosynthesis routinely affords highly pure quantities of [ <superscript>18</superscript> F]1, which will further enable tracer development of OP cholinesterase inhibitors and their evaluation in vivo.<br /> (Copyright © 2017 John Wiley & Sons, Ltd.)

Details

Language :
English
ISSN :
1099-1344
Volume :
60
Issue :
7
Database :
MEDLINE
Journal :
Journal of labelled compounds & radiopharmaceuticals
Publication Type :
Academic Journal
Accession number :
28406525
Full Text :
https://doi.org/10.1002/jlcr.3511